Jefferies Sees Much Larger Market Opportunity For AstraZeneca, Upgrades To Buy
September 12, 2016 at 09:33 AM EDT
Jefferies’ Jeffrey Holford believes there is a much higher probability of AstraZeneca plc (ADR) (NYSE: AZN) achieving success with ...